Patients

Vancouver City Council has voted to support a federal application that would allow a "compassion club" model and provide tested drugs in the city.

'We might need to make a move if Manitoba can't make a decision quickly,' says mom of boy with cystic fibrosis.

Cancer outcomes in Australia are among the best in the world, except for those in rural and remote areas.

'I need their help to help me save my child's life'.

​Why AARP keeps fighting to get your medication expenses under control.

Lyrica

Acthar

Revlimid

Copaxone

The list price for Trikafta in the U.S. is $310,000, meaning paying to fund the drug for one patient in Canada could be more than $400,000 a year.

Man previously denied new cystic fibrosis drug by Canada Life approved by different insurance company.

Such treatments are extraordinarily promising and costly. Will the Biden administration commit to spending that could speed clinical trial results?

Alexander Stockton, a producer on the Opinion Video team, explores two of the main reasons the number of Covid cases is soaring once again in the United States: vaccine hesitancy and refusal.

The options are slim for people who suffer rare life-altering injuries after a covid shot — a problem whose significance has grown as states and the federal government increasingly ponder vaccination mandates.

US Centers For Medicare and Medicaid Services doesn’t tip its hand on what, if anything, might replace the rule but says it is exploring ways to lower spending on Medicare Part B drugs.